CHO Pharma, Inc. (TPEX:6586)
Taiwan · Delayed Price · Currency is TWD 39.10
+0.30 (0.77%)
Sep 5, 2025, 1:17 PM CST
CHO Pharma Revenue
CHO Pharma had revenue of 712.00K TWD in the half year ending June 30, 2025. This brings the company's revenue in the last twelve months to 3.21M, up 196.67% year-over-year. In the year 2024, CHO Pharma had annual revenue of 3.58M.
Revenue (ttm)
3.21M
Revenue Growth
+196.67%
P/S Ratio
2,566.79
Revenue / Employee
n/a
Employees
n/a
Market Cap
8.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.58M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 60.00K | -3.51M | -98.32% |
| Dec 31, 2021 | 3.57M | 3.43M | 2,486.96% |
| Dec 31, 2020 | 138.00K | -159.00K | -53.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 44.83M |
| PharmaEssentia | 12.63B |
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| Lumosa Therapeutics | 37.25M |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |
| Center Laboratories | 1.60B |